The Antimicrobial and Synergistic Strategies of Erythromycin Combined Synthesized Chitosan-Silver and Chitosan-Zinc Oxide Nanodrug on Oral Bacteria

Author:

Ashour Amal Adnan1,Felemban Nayef H.2,Enan Enas T.3,Basha Sakeenabi4,Gad El-Rab Sanaa M. F.5

Affiliation:

1. Department of Oral and Maxillofacial Surgery and Diagnostic Sciences, Oral Pathology Division, Faculty of Dentistry, Taif University, Taif 26571, Saudi Arabia

2. Preventive Dentistry Department, Faculty of Dentistry, Taif University, Taif 26571, Saudi Arabia

3. Department of Dental Biomaterials, Faculty of Dentistry, Mansoura University, Mansoura 35511, Egypt

4. Department of Preventive and Community Dentistry, Faculty of Dentistry, Taif University, Taif 26571, Saudi Arabia

5. Department of Botany and Microbiology, Faculty of Science, Assiut University, 71516 Assiut, Egypt

Abstract

Dental infections cause chronic diseases, such as periodontitis and dental caries, thereby leading to the tooth loss. Antibacterial and antibiofilm efficiencies of silver and zinc oxide nanoparticles combined with chitosan and erythromycin against several bacterial oral diseases have been, therefore, demonstrated. Silver nanoparticles (TVE-AgNPs) were compared with a commercial ZnONPs that conjugated with chitosan to form TVE-AgNPs-CS and ZnONPs-CS. The synergistic efficiency of TVE-AgNPs-CS or ZnONPs-CS combined with erythromycin against Streptococcus mutans (S. mutans), Bacillus subtilis (B. subtilis) and Pseudomonas aeruginosa (P. aeruginosa) was estimated by broth micro-dilution assays, agar diffusion and biofilm formation. Herein, TVE-AgNPs were produced using Thymus vulgaris extract (TVE) and the peak obtained of TVE-AgNPs at 450 nm indicated the formation of TVE-AgNPs. Furthermore, results displayed the creation of spherical TVE-AgNPs with diameters a ranging from 10 to 24 nm. The FTIR analysis suggested that TVE contains reducing agents that consequently had a function in silver ions reduction and TVE-AgNPs formation. The minimum Inhibitory Concentration (MIC) value of TVE-AgNPs-CS and ZnONPs-CS with erythromycin exhibited an MIC value of 4–8 and 8–16 μg mL−1, respectively. The inhibition ratio versus biofilm was evaluated to be 75, 77.7, and 65.5% for S. mutans, B. subtilis and P. aeruginosa, respectively at TVE-AgNPs-CS/erythromycin concentration of 4 μg mL−1, while it was 91.6, 83.3, and 79.3% at ZnONPs-CS/erythromycin concentration of 8 μg mL−1. Our results provided an evidence of TVE-AgNPs-CS and ZnONPs-CS with erythromycin being antibacterial and antibiofilm agents against the tested bacteria. Also, they caused cell membrane damage of bacterial cells. Thus, ZnONPs-CS/erythromycin could be used in dental applications due to its non-toxicity profile and may be an important in the future development of more effective therapies for control of dental diseases.

Publisher

American Scientific Publishers

Subject

Renewable Energy, Sustainability and the Environment,Biomaterials,Bioengineering

Reference62 articles.

1. Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response;Grant;Virulence,2013

2. Advancing antimicrobial strategies for managing oral biofilm infections;Jiao;International Journal of Oral Science,2019

3. Periodontal-disease-associated biofilm: A reservoir for pathogens of medical importance;Colombo;Microbial Pathogenesis,2016

4. Candida albicans stimulates Streptococcus mutans microcolony development via cross-kingdom bioflm-derived metabolites;Kim;Scientific Reports,2017

5. Nicotine enhances interspecies relationship between Streptococcus mutans and Candida albicans;Liu;BioMed Research International,2017

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3